antiviral hyperactivation limiting therapeutics (ViroStatics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantiviral hyperactivation limiting therapeutics (ViroStatics)
Drug Alias NameVS1-002VS1-004
ClassificationSmall molecules
Mechanisms of ActionReverse transcriptase inhibitorsImmunomodulatorsHIV replication inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsInflammationImmune System DiseasesNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirostatics Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirostatics Srl
Active IndicationsN/A
Inactive IndicationsInflammationImmune System DiseasesNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A